Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2870324 | 0.98 | OPRM1 (0.37) | OPRM1FDPSALDH1A1TDP1TSHR | |
| Hydrochloric Acid SCHEMBL5087221 | 0.95 | OPRM1 (0.36) | OPRM1FDPSALDH1A1TDP1TSHR | |
| Bromide SCHEMBL5091502 | 0.95 | OPRM1 (0.36) | OPRM1FDPSALDH1A1TDP1TSHR | |
| Water SCHEMBL3485695 | 0.95 | OPRM1 (0.36) | OPRM1FDPSALDH1A1TDP1TSHR | |
| SCHEMBL3309843 | 0.91 | OPRM1 (0.41) | OPRM1FDPSALDH1A1TDP1TSHR | |
| Hydrochloric Acid SCHEMBL11826394 | 0.89 | OPRM1 (0.39) | OPRM1FDPSALDH1A1TDP1TSHR | |
| Iodide SCHEMBL5087118 | 0.89 | OPRM1 (0.44) | OPRM1FDPSCA1SPHK1 | |
| SCHEMBL3311714 | 0.88 | OPRM1 (0.37) | OPRM1FDPSALDH1A1TDP1TSHR | |
| SCHEMBL3304504 | 0.88 | OPRM1 (0.37) | OPRM1FDPSALDH1A1TDP1SPHK1 | |
| Iodide SCHEMBL5084887 | 0.87 | OPRM1 (0.43) | OPRM1FDPSDNM1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215165-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | VITO NV (BE) | 2025-07-03 | — | — | US | claimed |
| EP-4529538-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | Vito NV (BE) | 2025-04-02 | — | — | EP | claimed |
| CN-119301138-A | Lignin-derived cyclic carbonate monomers | 佛兰芒技术研究所有限公司 | 2025-01-10 | — | — | CN | claimed |
| WO-2023227426-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | VITO NV (BE) | 2023-11-30 | — | — | WO | claimed |
| EP-4282870-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | Vito NV (BE) | 2023-11-29 | — | — | EP | claimed |
| US-20250215165-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | VITO NV (BE) | 2025-07-03 | — | — | US | disclosed |
| EP-4529538-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | Vito NV (BE) | 2025-04-02 | — | — | EP | disclosed |
| CN-119301138-A | Lignin-derived cyclic carbonate monomers | 佛兰芒技术研究所有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2023227426-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | VITO NV (BE) | 2023-11-30 | — | — | WO | disclosed |
| EP-4282870-A1 | LIGNIN-DERIVED CYCLOCARBONATE MONOMERS | Vito NV (BE) | 2023-11-29 | — | — | EP | disclosed |
| US-20080214386-A1 | Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-1590316-A1 | METHOD FOR PURIFYING CHLOROMETHYL CHLOROFORMATE | PPG Industries Ohio, Inc. (US) | 2005-11-02 | — | — | EP | disclosed |
| US-6911558-B2 | Method for purifying chloromethyl chloroformate | PPG INDUSTRIES OHIO, INC. (US) | 2005-06-28 | — | — | US | disclosed |
| WO-2004072014-A1 | METHOD FOR PURIFYING CHLOROMETHYL CHLOROFORMATE | PPG INDUSTRIES OHIO INC. (US) | 2004-08-26 | — | — | WO | disclosed |
| US-20040152911-A1 | Method for purifying chloromethyl chloroformate | ROYAL MOULDINGS LIMITED | 2004-08-05 | — | — | US | disclosed |
| US-4814524-A | Method for converting organic chloroformate to the corresponding organic chloride | PPG INDUSTRIES, INC. (US) | 1989-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152911-A1 | Method for purifying chloromethyl chloroformate | MCCC2, CMBL, CBX3 | OPRM1 1004/4885FDPS 2021/4885ALDH1A1 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.